Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. - Wikidata - wikimedia - TriplyDB

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.

http://www.wikidata.org/entity/Q38261649

about

Mutations in NOTCH1 cause aortic valve disease Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis Cellular mechanisms of aortic valve calcification Diagnosis and management of patients with asymptomatic severe aortic stenosis In vitro models of aortic valve calcification: solidifying a system C-reactive protein in aortic valve disease C-reactive protein in degenerative aortic valve stenosis Is there a role of statins in the prevention of aortic biological prostheses degeneration Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.Calcific aortic valve stenosis: methods, models, and mechanisms Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.A computational model of aging and calcification in the aortic heart valve Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.Left-sided cardiac valvulitis in tristetraprolin-deficient mice: the role of tumor necrosis factor alpha.Effect of Rosuvastatin on Bovine Pericardial Aortic Tissue Valve Calcification in a Rat Subdermal Implantation Model Anion-exchange HPLC separation of five major rabbit lipoproteins using a nonporous diethylaminoethyl-ligated gel with a perchlorate-containing eluent.Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation Serotonin receptors and heart valve disease--it was meant 2B.Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease Quantitative cardiovascular magnetic resonance for molecular imaging.Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis).Modified lipoprotein-derived lipid particles accumulate in human stenotic aortic valves.Bicuspid aortic valve disease: the role of oxidative stress in Lrp5 bone formation.Defining the role of fluid shear stress in the expression of early signaling markers for calcific aortic valve disease.Animal models of calcific aortic valve disease Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts.Role for circulating osteogenic precursor cells in aortic valvular disease.Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis.Pathogenesis of aortic stenosis: not just a matter of wear and tear Cellular Changes during Renal Failure-Induced Inflammatory Aortic Valve Disease.The role of Lrp5/6 in cardiac valve disease: experimental hypercholesterolemia in the ApoE-/- /Lrp5-/- mice.Effect of hydroxymethylglutaryl coenzyme-a reductase inhibitors on the long-term progression of rheumatic mitral valve disease.Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(-/-) null mice.Is it time for medical therapy for aortic valve disease?The association of hypertension and aortic valve sclerosis.

P2860

Q24307999-3FD4A2ED-1B25-4CD9-9FAF-1971E252CD7A Q24595023-4C6A5FE1-C6E3-4AFF-919A-BF3ED3275EA3 Q24613042-FEC54739-AED6-4915-8743-C21D0A7A9930 Q26765161-AA190B04-17D8-4E3F-AD40-FDBA847DF260 Q27022156-61FE349A-7026-4A05-86E4-CE63AF7A1282 Q28200692-82F58576-1415-41BD-892A-03A894EEAE37 Q28219092-05C09B7F-116F-4191-8AF4-B8C78000CC7A Q28219702-F616C088-91A8-4B99-8FCE-D8545F220CA2 Q30234828-580E20D3-27D2-4DD7-BD83-FFDE8F73D700 Q30474772-CD9C62CF-9D12-4A7C-85D4-8E9BA2D560ED Q30503246-E8028022-65B5-49D0-A1FD-1443A89B0846 Q31111874-E417ECBD-361D-4D3E-AA10-FDD8B997B48E Q33414426-ED8B3E64-CD2A-412E-8AB6-DFDEAD425719 Q33470232-99C9568B-7D4A-42D3-9157-33A66D53A418 Q33589249-7CC430DD-FBE3-425D-BA4B-380A4F4366B5 Q33703816-ED714DD2-19E0-4D7D-876A-2FC83C40650A Q33740831-FA36A3E6-B755-4F39-8D8A-D0BB094F7A6A Q33993189-F94EC0A6-335E-4F67-8E89-D39305BA83A9 Q34065287-621EFF62-8C1F-4EC9-881C-ADCE4F767C44 Q34173511-4D5E1A14-ACB3-4AF5-B988-D6D20F2CAB97 Q34252285-08CC8583-7C29-464F-86C5-5D5C7FE2DDFE Q34330885-172C2FE5-04DC-419A-8064-4595017CBCC0 Q34363159-37E0051A-2819-4FC8-AE80-186D6B881BE7 Q34418799-F3A0C31D-336A-438D-8D9C-5CEA3FBB84F2 Q34770283-9818B8DB-733C-473A-BD39-0AA826FAB7A6 Q34900192-B1001A73-DDC6-4B31-974E-068125B05E22 Q35078393-56D5A733-CFC0-4239-94DE-C54AFD82015B Q35147157-0197618D-619B-44F4-A3EF-47036182245F Q35154908-39DE3D9B-15C7-4070-AB45-7160EB25E9D6 Q35563353-62ACA0FF-5ECC-4EB3-A080-B613EF2C525E Q35584233-8A240B7D-1537-4A8F-9DA1-D1E6AA9229FD Q35635352-17B7A99C-084D-4C57-A916-3ACD564958AA Q35660101-2D4267BE-B49A-49D2-8A0A-1AA377201B9E Q35662347-0DF1BA51-2AA6-42F1-A4DD-2898C4CB193A Q35686702-73D168EA-3DA1-42B5-9C4E-75944AA0563A Q35686707-7BA63310-ED4C-464C-8B8F-07E63E808530 Q35836894-DAD3A0EC-B532-422F-BAA3-72D327839C4C Q35914664-0FD96EE4-769A-42DC-A69C-F1F7A18B895E Q35925688-775F00F0-AF34-4ED6-A9C9-8DE4257F685F Q36300823-33B57D0F-D945-44D9-9B7F-BAA9FF764FBF

P2860

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.

http://www.wikidata.org/entity/Q38261649

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Atorvastatin inhibits hypercho ...... on in the rabbit aortic valve.

@en

type

label

Atorvastatin inhibits hypercho ...... on in the rabbit aortic valve.

@en

prefLabel

Atorvastatin inhibits hypercho ...... on in the rabbit aortic valve.

@en

P1433

Q38261649-C74846DD-CB34-4898-B6C6-EB3E9CA55CB9

P1476

Q38261649-945174B1-67CC-4A15-B8AF-38D2ED7A07E4

P2093

Q38261649-2AB0F1D3-3240-48CF-9DBF-FB93327BAFFA

Q38261649-2B957CAB-E807-4642-8F1C-BCC191B96A3B

Q38261649-3B285E59-D8F2-4650-8A26-977981FB5266

Q38261649-5CDC5DF1-EC8E-4FB2-A4EA-B75FF6DF8FA6

Q38261649-73A91BE8-5313-4F1F-93BF-EB29CEA44711

Q38261649-94245D65-1199-4B39-99C8-7ED1386F2B3B

Q38261649-956BFB40-2127-4E35-87C3-D995FE844940

Q38261649-9C37A7A6-BAB6-49A6-A4EE-C446C769C231

Q38261649-E5375937-F53E-4538-B73E-584FA372D6D3

Q38261649-EF557A5F-5561-499B-80DC-E005DCE6D4F1

P2860

Q38261649-0783E913-05D8-47C9-A313-3E9C3241A926

Q38261649-0BC0E26D-114B-4633-B103-5DCFF2210158

Q38261649-1D7DE3AA-D6E8-47E2-8C07-22D0174EC42A

Q38261649-2CFE90A3-00CF-47E0-B962-C14F1F1D858C

Q38261649-67291363-B594-45F2-9512-100CE688DAB4

Q38261649-86BCE330-9956-4A12-BBB0-A87A6A2F2BAE

Q38261649-91614A05-2ADE-4146-9695-EAECBFD58962

Q38261649-A9E219B2-3D9A-4474-968B-6E23497E85FC

Q38261649-AE202BF3-E1D6-4F08-9777-F1952A798858

Q38261649-BEC7B80B-ADDD-414A-B093-327357B1D2C3

P304

Q38261649-5FCB4001-A1C1-4C40-80A9-E5F6BCAE0B0A

P31

Q38261649-0FA8E54F-FEE0-401F-B676-EC5EFC952A16

P356

Q38261649-9FC0B97F-3172-46AE-9EF6-F65307C4F40C

P407

Q38261649-3CFFBD63-BF8B-406A-89B2-77269D248C54

P433

Q38261649-74FD3C78-65CE-4A1F-BE12-1FAA22B30E18

P478

Q38261649-78E0EB4C-AE7B-40C8-B558-D25428F4D167

P577

Q38261649-5E2451F5-908D-4D94-935D-542F168B532A

P5875

Q38261649-AFC5EE3D-3CD0-4EFC-A9EC-D7759B1B114B

P698

Q38261649-2CAF0D41-1915-42A2-8954-9E153D493A6C

P921

Q38261649-6547FDDC-7074-468F-9332-1EE384FA55AD

Q38261649-A86A2588-DB02-47E9-AF78-E6299AFFA689

P932

Q38261649-B9E13F90-0DAF-4471-A658-D31677BA9D46

P356

01.CIR.0000017435.87463.72

P1433

P1476

Atorvastatin inhibits hypercho ...... on in the rabbit aortic valve.

@en

P2093

Joseph P McConnell

http://www.w3.org/2001/XMLSchema#string

Malayannan Subramaniam

http://www.w3.org/2001/XMLSchema#string

Marek Niekrasz

http://www.w3.org/2001/XMLSchema#string

Margaret Springett

http://www.w3.org/2001/XMLSchema#string

Nalini M Rajamannan

http://www.w3.org/2001/XMLSchema#string

Neil J Stone

http://www.w3.org/2001/XMLSchema#string

Ravinder J Singh

http://www.w3.org/2001/XMLSchema#string

Robert O Bonow

http://www.w3.org/2001/XMLSchema#string

Thomas C Sebo

http://www.w3.org/2001/XMLSchema#string

Thomas C Spelsberg

http://www.w3.org/2001/XMLSchema#string

P2860

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

Phosphate is a specific signal for induction of osteopontin gene expression

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors.

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.

The osteoblast: a sophisticated fibroblast under central surveillance.

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

C-reactive protein is increased in patients with degenerative aortic valvular stenosis.

Isolation and characterization of osteoblast precursor cells from human bone marrow.

Digital image analysis.

P304

2660-2665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000017435.87463.72

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11328459

http://www.w3.org/2001/XMLSchema#string

P698

12045173

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

3951862

http://www.w3.org/2001/XMLSchema#string